EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study

Fang Yan, Wanyu Wang, Zhiwen Yang, Yang Huang, Yan Rao, Ge Qu, Hui Peng, Ming Shi, Weian Zeng, Dongtai Chen, Wei Xing

British Journal of Anaesthesia · 2025-06 · 134 (6) · 1628-1637

DOI: 10.1016/j.bja.2025.01.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2025-06. Verfasst von Fang Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Lidocaine, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lidocaine, the most widely used local anaesthetic, has anticancer effects in both laboratory findings and retrospective clinical studies. We explored the potential benefits of intra-arterial lidocaine on long-term survival in patients with hepatocellular carcinoma (HCC) undergoing transcatheter arterial chemoembolisation (TACE). METHODS: This retrospective cohort study included patients with HCC who received TACE as initial treatment from August 2011 to October 2016. Eligible patients were categorised into no lidocaine and lidocaine groups. Propensity score matching was undertaken. Progression-free survival (PFS) and overall survival were compared between the two groups. Subgroup analysis was performed to explore the survival benefit of combining intra-arterial lidocaine with platinum-based chemotherapy during TACE. RESULTS: Of 374 eligible patients, 96 were in the lidocaine group and 278 were in the no lidocaine group. Survival analysis showed that intra-arterial lidocaine was associated with longer PFS (P=0.004) and overall survival (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLidocaineLiver NeoplasmsChemoembolization, TherapeuticAnesthetics, LocalHumansFemaleRetrospective StudiesMalePropensity ScoreMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

hepatocellular carcinomaintra-arterial lidocaine administrationlong-term survivalpropensity score matchingtranscatheter arterial chemoembolisation

Substanzen

LidocaineAnesthetics, Local

Autor:innen und Institutionen

  • Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Department of Anesthesiology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, PR China.
  • Department of Anesthesiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, PR China.
  • Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China. Electronic address: che…
  • Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China. Electronic address: xin…

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Yan, F., Wang, W., Yang, Z., Huang, Y., Rao, Y., Qu, G., Peng, H., Shi, M., Zeng, W., Chen, D., & Xing, W. (2025). Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study. British Journal of Anaesthesia, 134(6), 1628-1637. https://doi.org/10.1016/j.bja.2025.01.042

Vancouver

Yan F, Wang W, Yang Z, Huang Y, Rao Y, Qu G, et al. Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study. British Journal of Anaesthesia. 2025;134(6):1628-1637. doi:10.1016/j.bja.2025.01.042

BibTeX
@article{Yan2025,
  author = {Yan, Fang and Wang, Wanyu and Yang, Zhiwen and Huang, Yang and Rao, Yan and Qu, Ge and Peng, Hui and Shi, Ming and Zeng, Weian and Chen, Dongtai and Xing, Wei},
  title = {Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  volume = {134},
  number = {6},
  pages = {1628--1637},
  doi = {10.1016/j.bja.2025.01.042}
}
Kostenlos starten →